TD Asset Management’s Abivax ABVX Stock Holding History
Bought
Maintained
Sold
Other funds holding ABVX
DGM
TD Asset Management's ABVX Position: Q3 2026 in Review
TD Asset Management reduced its Abivax (ABVX) stake by 17% in Q3 2026, selling an estimated $338K and leaving 14,148 shares worth $1.39M. The position accounts for ﹤0.01% of the portfolio, ranked #1033.
TD Asset Management first reported a position in ABVX in Q3 2025 and has held it in 5 quarters since. The position peaked at $8.62M in Q4 2025. 319 funds tracked by Wall St. Rank hold ABVX as of Q3 2026.
- TD Asset Management held 14,148 shares of Abivax worth $1.39M as of Q3 2026.
- TD Asset Management sold 2,800 Abivax shares in Q3 2026, an estimated $338K.
- Abivax made up ﹤0.01% of TD Asset Management's portfolio in Q3 2026, its #1033 holding.
- TD Asset Management first reported a position in Abivax in Q3 2025 and has held it in 5 quarters since.
- TD Asset Management's Abivax position peaked at $8.62M in Q4 2025.
- 319 funds tracked by Wall St. Rank held Abivax as of Q3 2026.
Based on TD Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.